Arvin Iracheta-Vellve
5PUBLICATIONS
72CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 04, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.Christina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve
|Mar 02, 2023
Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation.Marcelle de Carvalho Ribeiro, Arvin Iracheta-Vellve, Mrigya Babuta
|Jan 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapy.Yi Sun, Or-Yam Revach, Seth Anderson
|Sep 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.Juan Dubrot, Peter P Du, Sarah Kate Lane-Reticker
|May 06, 2021
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.Gabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve
Pageof 1
Frequent Collaborators
4 joint publications
Robert T Manguso
3 joint publications
Nelson H Knudsen
3 joint publications
Kathleen B Yates
2 joint publications
James C Patti
2 joint publications
Nir Hacohen
2 joint publications
Peter P Du
2 joint publications
Kira E Olander
2 joint publications
Emily M Schneider
2 joint publications
Audrey J Muscato
2 joint publications
John G Doench
